HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

6th Edition of

Singapore Nursing Research Conference

March 19-21, 2026 | Singapore

Oncolytic Virotherapy

Oncolytic Virotherapy

Oncolytic virotherapy stands at the forefront of innovation in cancer treatment, utilizing viruses to target and eradicate cancer cells selectively. The ethical considerations in oncolytic virotherapy encompass several dimensions. Patient safety takes center stage, requiring rigorous evaluation and monitoring in experimental treatments. Obtaining informed consent becomes crucial as patients navigate the complexities of participating in clinical trials, emphasizing transparency about potential risks and benefits. Ethical frameworks also address the equitable access to these emerging therapies, ensuring that the benefits of oncolytic virotherapy are shared widely. As the field advances, ongoing ethical discourse guides the responsible integration of this novel approach into mainstream cancer care, balancing the pursuit of groundbreaking treatments with ethical responsibility and patient well-being.

Committee Members
Speaker at Singapore Nursing Research Conference 2026 - Nina Beaman

Nina Beaman

Aspen University, United States
Speaker at Singapore Nursing Research Conference 2026 - Patricia M Burrell

Patricia M Burrell

Hawaii Pacific University, United States
Speaker at Singapore Nursing Research Conference 2026 - David John Wortley

David John Wortley

International Society of Digital Medicine, United Kingdom
NURSING 2026 Speakers
Speaker at Singapore Nursing Research Conference 2026 - Mirjana Markovic

Mirjana Markovic

South University, United States
Speaker at Singapore Nursing Research Conference 2026 - Liz King

Liz King

The Open University, United Kingdom
Speaker at Singapore Nursing Research Conference 2026 - Fabiola Sevilla Perez

Fabiola Sevilla Perez

University College of London Hospital, United Kingdom

Submit your abstract Today

Watsapp